Recently Published Study Examines a Novel Drug Candidate for the Treatment of neuroHIV
The study, led by Dr. Kumar and his team, including recent graduate Dr. Mirzahosseini, from the Department of Pharmaceutical Sciences and the Department of Anatomy and Neurobiology at the University of Tennessee Health Science Center in Memphis, suggests that the LM11A-31 compound could be a promising new treatment for neuroHIV and HAND.